人工智能在肝脏疾病中的诊断应用
Maria Consiglia Bragazzi1, Rosanna Venere1, Gloria Andriollo1
1Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.
人工智能 (AI) 为诊断和治疗肝硬化和瘤等肝病提供了新的工具. 这篇评论强调了最近在肝病学领域的AI进步,改善了患者护理.
科学领域:
- *肝病学和人工智能 (AI) 的研究
背景情况:
- * 慢性肝病,肝硬化,原发性肝瘤和肝转移是全球主要的死亡原因.
- * 在肝病管理中,对先进的诊断和治疗工具的需求越来越大.
研究的目的:
- * 审查肝病学内人工智能应用的最新进展.
- * 探索人工智能如何提高肝脏疾病的诊断和治疗.
主要方法:
- * 关于最近人工智能在肝病学方面的进展的文献综述.
- * 分析AI在诊断和治疗各种肝脏疾病中的作用.
主要成果:
- *人工智能越来越多地被用于提高肝脏疾病的诊断准确性和治疗疗效.
- *新兴的人工智能工具显示出在肝病学中更有效和最少侵入性的方法的希望.
结论:
- *人工智能具有显著的潜力,可以彻底改变肝脏疾病的管理.
- *人工智能领域的持续研究和开发对于推进肝病学和患者结果至关重要.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
05:33Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
